APOC3 and coronary artery disorder: Because apoC-III may inhibit anti-atherogenic actions of HDL,25 we aimed to compare plasma concentrations of total HDL, HDL that has apoC-III, and HDL without apoC-III as predictors of the risk of CHD in two prospective studies of US women and men initially free of CHD.